Page 196 - Read Online

Tagliari et al. Vessel Plus 2020;4:16 Vessel Plus
DOI: 10.20517/2574-1209.2020.05

Review Open Access

Transcatheter aortic valve implantation combined
with other heart interventions: current status and

future perspectives

Ana Paula Tagliari , Maurizio Taramasso 1
1,2
1 Cardiac Surgery Department, University Hospital of Zurich, University of Zurich, Zurich 8091, Switzerland.
2 Postgraduate Program in Health Sciences, Cardiology and Cardiovascular Sciences, Universidade Federal do Rio Grande do Sul,
Porto Alegre 2400, Brazil.

Correspondence to: Dr. Ana Paula Tagliari, Cardiovascular Surgery Department, University Hospital of Zurich, Rämistrasse 100,
Zurich 8091, Switzerland. E-mail: anapaula.tagliari@usz.ch

How to cite this article: Tagliari AP, Taramasso M. Transcatheter aortic valve implantation combined with other heart
interventions: current status and future perspectives. Vessel Plus 2020;4:16. http://dx.doi.org/10.20517/2574-1209.2020.05

Received: 19 Jan 2020 First Decision: 16 Mar 2020 Revised: 18 Mar 2020 Accepted: 20 Mar 2020 Published: 16 Jun 2020
Science Editor: Mario F. L. Gaudino Copy Editor: Jing-Wen Zhang Production Editor: Jing Yu

Received: First Decision: Revised: Accepted: Published: x
Abstract
Science Editor: Copy Editor: Production Editor: Jing Yu
Transcatheter aortic valve implantation is a well-proven effective treatment option for patients with severe
symptomatic aortic valve stenosis requiring valve replacement in all risk classes. Frequently, however, other
concomitant cardiovascular conditions demanding intervention are present, and a combined approach is required.
Here, we discuss some of the most frequent combined settings. The decision about which approach (staged
or simultaneous) is more suitable for each patient needs to be based on individual characteristics and clinical,
anatomical, and procedure-related factors.

Keywords: Transcatheter aortic valve implantation, combined procedure, heart valve disease, percutaneous
coronary intervention, outcomes

INTRODUCTION
In the last years, transcatheter aortic valve implantation (TAVI) has become a well-proven effective
treatment option for patients with severe symptomatic aortic valve stenosis (AS) requiring valve
replacement at high or intermediate surgical risk. Nowadays, with the expansion of TAVI for low-risk
populations, the number of individuals undergoing TAVI will increase even more. Frequently, however,

© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0
International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made.

www.vpjournal.net